Navigation Links
Molecular Imaging Services, Inc. Performs First Rubidium-82 Cardiac PET Scan In Delaware
Date:4/3/2013

WILMINGTON, Del., April 3, 2013 /PRNewswire/ -- Molecular Imaging Services, Inc. (MIS) is pleased to announce that it has performed the first Rubidium-82 Myocardial Perfusion PET scan in its newly opened office at Omega Medical Center located in Newark, Delaware.  Myocardial Perfusion PET Imaging is a powerful tool in the assessment of coronary artery disease (CAD) and has been shown to have clear advantages over conventional SPECT Myocardial Perfusion Imaging. The higher sensitivity, specificity and accuracy of Cardiac PET Imaging can potentially reduce the downstream healthcare costs associated with CAD by decreasing the need for more expensive and higher risk, invasive procedures.

MIS is the first in Delaware to help diagnose heart disease using this advanced imaging technique. "We are excited and extremely pleased to provide access to this technology for the physicians and their patients in our community.  The increased sensitivity, specificity and accuracy of Cardiac PET are well documented making it a powerful diagnostic tool for physicians. We are thrilled to be the first to perform Cardiac PET Perfusion Imaging in Delaware.  MIS also plans to use this PET scanner for brain imaging and research to help advance the field of Molecular Imaging," said Frank DiGregorio , President and CEO of MIS.

About Molecular Imaging Services, Inc.
Headquartered in Wilmington, Delaware, Molecular Imaging Services, Inc. is a privately held company that operates nuclear imaging services nationwide.  With many years of combined experience in the molecular imaging industry, MIS offers nuclear cardiology technologies including SPECT and PET.  For more information, visit www.mismedical.com or send email to info@mismedical.com

 


'/>"/>
SOURCE Molecular Imaging Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
4. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
5. The 2012 US Molecular Diagnostics Market
6. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
7. BSGI Molecular Breast Imaging Proves Equivalent to MRI in Breast Cancer Patient Management
8. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
9. Science Translational Medicine and the DMM Global Foundation Announce Days of Molecular Medicine 2012 "The Translational Science of Rare Diseases: From Rare To Care."
10. IBA Molecular, Piramal Imaging Sign Agreement for New F-18 Amyloid Imaging Agent
11. New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... The vast majority of dialysis patients currently ... are usually 3 times a week, with treatment times ... time, equipment preparation and wait time.  This regimen can ... patients who are elderly and frail.  Many elderly dialysis ... centers for some duration of time. Residents ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... with extensive sequencing and genomics experience, as Vice President of North American Capital Sales ... be responsible for leading the sales team in the commercialization of the HTG EdgeSeq ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):